PBMs: Part of the Solution to High Drug Prices

PBMs: Part of the Solution to High Drug Prices

Recently, three changes in the health care terrain collided to raise new concerns over rising drug prices: the advent of new high-priced “wonder drugs” like Sovaldi; revelations that Turing Pharmaceuticals and others bought the rights to low-cost drugs in order to re-price them at higher levels, and the enrollment of millions in the new ACA Exchange high-deductible plans, which enabled consumers to see the real price of drugs, not just the copays.

Read More